4.5 Article

Over-represented sequences located on 3′ UTRs are potentially involved in regulatory functions

期刊

RNA BIOLOGY
卷 5, 期 4, 页码 255-262

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/rna.7116

关键词

3 ' UTR; post-transcriptional regulation; regulatory sequences; RNA binding proteins; gene networks; translation; mRNA stability

资金

  1. Computational Biology Initiative (UTSA/UTHSCSA)
  2. UTSA College of Business

向作者/读者索取更多资源

Eukaryotic gene expression must be coordinated for the proper functioning of biological processes. This coordination can be achieved both at the transcriptional and post-transcriptional levels. In both cases, regulatory sequences placed at either promoter regions or on UTRs function as markers recognized by regulators that can then activate or repress different groups of genes according to necessity. While regulatory sequences involved in transcription are quite well documented, there is a lack of information on sequence elements involved in post-transcriptional regulation. We used a statistical over-representation method to identify novel regulatory elements located on UTRs. An exhaustive search approach was used to calculate the frequency of all possible n-mers (short nucleotide sequences) in 16,160 human genes of NCBI RefSeq sequences and to identify any peculiar usage of n-mers on UTRs. After a stringent filtering process, we identified 2,772 highly over-represented n-mers on 3' UTRs. We provide evidence that these n-mers are potentially involved in regulatory functions. Identified n-mers overlap with previously identified binding sites for HuR and TIA-1 and, ARE and GRE sequences. We determine also that n-mers overlap with predicted miRNA target sites. Finally, a method to cluster n-mer groups allowed the identification of putative gene networks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis

Hye-Young Nam, Darshan S. Chandrashekar, Anirban Kundu, Sandeep Shelar, Eun-Young Kho, Guru Sonpavde, Gurudatta Naik, Pooja Ghatalia, Carolina B. Livi, Sooryanarayana Varambally, Sunil Sudarshan

MOLECULAR CANCER RESEARCH (2019)

Article Oncology

Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer

Robert S. Svatek, Niannian Ji, Essel de Leon, Neelam Z. Mukherjee, Aashish Kabra, Vincent Hurez, Marlo Nicolas, Joel E. Michalek, Martin Javors, Karen Wheeler, Z. Dave Sharp, Carolina B. Livi, Zhen-Ju Shu, David Henkes, Tyler J. Curiel

CANCER IMMUNOLOGY RESEARCH (2019)

Article Oncology

ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State

Adam Kosti, Liqin Du, Haridha Shivram, Mei Qiao, Suzanne Burns, Juan Gabriel Garcia, Alexander Pertsemlidis, Vishwanath R. Iyer, Erzsebet Kokovay, Luiz O. F. Penalva

MOLECULAR CANCER RESEARCH (2020)

Article Cell & Tissue Engineering

Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis

Zhe Zhu, Pinar Mesci, Jean A. Bernatchez, Ryan C. Gimple, Xiuxing Wang, Simon T. Schafer, Hiromi Wettersten, Sungjun Beck, Alex E. Clark, Qiulian Wu, Briana C. Prager, Leo J. Y. Kim, Rekha Dhanwani, Sonia Sharma, Alexandra Garancher, Sara M. Weis, Stephen C. Mack, Priscilla D. Negraes, Cleber A. Trujillo, Luiz O. Penalva, Jing Feng, Zhou Lan, Rong Zhang, Alex W. Wessel, Sanjay Dhawan, Michael S. Diamond, Clark C. Chen, Robert J. Wechsler-Reya, Fred H. Gage, Hongzhen Hu, Jair L. Siqueira-Neto, Alysson R. Muotri, David A. Cheresh, Jeremy N. Rich

CELL STEM CELL (2020)

Article Genetics & Heredity

Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles

Gabriela D. A. Guardia, Bruna R. Correa, Patricia Rosa Araujo, Mei Qiao, Suzanne Burns, Luiz O. F. Penalva, Pedro A. F. Galante

NPJ GENOMIC MEDICINE (2020)

Article Immunology

PRDM16 suppresses HIF-targeted gene expression in kidney cancer

Anirban Kundu, Hyeyoung Nam, Sandeep Shelar, Darshan S. Chandrashekar, Garrett Brinkley, Suman Karki, Tanecia Mitchell, Carolina B. Livi, Phillip Buckhaults, Richard Kirkman, Yawen Tang, Glenn C. Rowe, Shi Wei, Sooryanarayana Varambally, Sunil Sudarshan

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Multidisciplinary Sciences

Genomic analyses of early responses to radiation inglioblastoma reveal new alterations at transcription,splicing, and translation levels

Saket Choudhary, Suzanne C. Burns, Hoda Mirsafian, Wenzheng Li, Dat T. Vo, Mei Qiao, Xiufen Lei, Andrew D. Smith, Luiz O. Penalva

SCIENTIFIC REPORTS (2020)

Correction Multidisciplinary Sciences

Genomic analyses of early responses to radiation in glioblastoma reveal new alterations at transcription, splicing, and translation levels (vol 10, 8979, 2020)

Saket Choudhary, Suzanne C. Burns, Hoda Mirsafian, Wenzheng Li, Dat T. Vo, Mei Qiao, Xiufen Lei, Andrew D. Smith, Luiz O. Penalva

SCIENTIFIC REPORTS (2020)

Article Oncology

MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation

Rebecca Poetschke, Jacob Haase, Markus Glass, Sebastian Simmermacher, Claudia Misiak, Luiz O. F. Penalva, Caspar D. Kuehnoel, Stefan Huettelmaier

CANCERS (2020)

Article Oncology

Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells

Adam Kosti, Rodrigo Barreiro, Gabriela D. A. Guardia, Shiva Ostadrahimi, Erzsebet Kokovay, Alexander Pertsemlidis, Pedro A. F. Galante, Luiz O. F. Penalva

Summary: miRNAs act as key regulators of gene expression, contributing to cancer phenotypes as oncogenes or tumor suppressors. Cooperative action of miRNAs regulates biological processes and pathways, suggesting that miRNA combinations could be more effective in targeting cancer stem cells. Using combinations of tumor suppressor miRNAs may offer new routes to disrupt cancer phenotypes and growth of cancer-initiating cell populations.

CANCERS (2021)

Article Oncology

Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy

Carla Frau, Catherine Jamard, Gaspard Delpouve, Gabriela D. A. Guardia, Christelle Machon, Camilla Pilati, Clementine Le Neve, Pierre Laurent-Puig, Jerome Guitton, Pedro A. F. Galante, Luiz O. Penalva, Jean-Noel Freund, Christelle de la Fouchardiere, Michelina Plateroti

Summary: The study reveals paradoxical roles of MSI1 in both facilitating intestinal regeneration after injury and promoting drug-resistant colorectal cancer stem cells. Increased levels of MSI1 contribute to the reprogramming of progenitor cells into drug-resistant phenotypes, highlighting its importance in chemotherapy resistance and tumor grading in colorectal cancer patients. These findings shed light on the biology and plasticity of normal and cancer cell populations, presenting potential new targets for improving chemotherapy outcomes.

CANCER RESEARCH (2021)

Article Oncology

Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes

Mirella Baroni, Caihong Yi, Saket Choudhary, Xiufen Lei, Adam Kosti, Denise Grieshober, Mitzli Velasco, Mei Qiao, Suzanne S. Burns, Patricia R. Araujo, Talia DeLambre, Mi Young Son, Michelina Plateroti, Marco A. R. Ferreira, E. Paul Hasty, Luiz O. F. Penalva

Summary: RNA binding protein Msi1 plays a crucial role in glioblastoma by regulating cell cycle and DNA replication genes, impacting tumor growth and response to therapy. High levels of Msi1 are associated with poor prognosis and tumor growth in multiple cancers.

CANCERS (2021)

Article Neurosciences

Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches

Sajina Shakya, Anthony D. Gromovsky, James S. Hale, Arnon M. Knudsen, Briana Prager, Lisa C. Wallace, Luiz O. F. Penalva, H. Alex Brown, Bjarne W. Kristensen, Jeremy N. Rich, Justin D. Lathia, J. Mark Brown, Christopher G. Hubert

Summary: Glioblastoma displays significant cellular and metabolic heterogeneity, with striking differences in lipid metabolism across different microenvironments, and cancer stem cells (CSCs) also show altered lipid metabolism. The differences in lipid metabolism may not only be a product of the microenvironment, but also a reflection of cellular state, providing new insights into therapeutic targets for GBM.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Structural Characterization of the RNA-Binding Protein SERBP1 Reveals Intrinsic Disorder and Atypical RNA Binding Modes

Antoine Baudin, Alma K. Moreno-Romero, Xiaoping Xu, Emily E. Selig, Luiz O. F. Penalva, David S. Libich

Summary: RNA binding proteins (RBPs) such as SERBP1 play crucial roles in mRNA processing and translation regulation, with implications in diseases like cancer and neurodegeneration. Despite being initially identified as a hyaluronic acid binding protein, SERBP1 is now recognized for its central roles in brain function and development, including neurogenesis and synaptogenesis. Studies have shown that SERBP1 regulates One-carbon metabolism and epigenetic modification of histones, with increased expression in various cancers correlating with poor patient outcomes. Further research on SERBP1's structural and dynamic properties, as well as its interaction mechanisms with RNA, contribute to the understanding of its functions in physiological and pathological processes.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biotechnology & Applied Microbiology

The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation

Adam Kosti, Patricia Rosa de Araujo, Wei-Qing Li, Gabriela D. A. Guardia, Jennifer Chiou, Caihong Yi, Debashish Ray, Fabiana Meliso, Yi-Ming Li, Talia Delambre, Mei Qiao, Suzanne S. Burns, Franziska K. Lorbeer, Fanny Georgi, Markus Flosbach, Sarah Klinnert, Anne Jenseit, Xiufen Lei, Carolina Romero Sandoval, Kevin Ha, Hong Zheng, Renu Pandey, Aleksandra Gruslova, Yogesh K. Gupta, Andrew Brenner, Erzsebet Kokovay, Timothy R. Hughes, Quaid D. Morris, Pedro A. F. Galante, Stefano Tiziani, Luiz O. F. Penalva

GENOME BIOLOGY (2020)

暂无数据